Clinical trial
ARISE - Aggressive Reduction of Inflammation Stops Events
NCT00066898 · AtheroGenics, Industry · Unknown status
Key facts
| NCT number | NCT00066898 |
|---|---|
| Title | ARISE - Aggressive Reduction of Inflammation Stops Events |
| Official title | "Reduction of Vascular Inflammation and Coronary Atherosclerosis With AGI-1067, a V-Protectant, Reduces Cardiovascular Events in Patients With Coronary Artery Disease" |
| Lead sponsor | AtheroGenics, Industry |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Atherosclerosis, Coronary Artery Disease, Myocardial Infarction, Unstable Angina |
| Intervention type | Drug |
| Interventions | AGI-1067 |
| Enrollment | 6,000 |
| Start date | Jun 1, 2003 |
| Completion | Dec 1, 2006 |
| First posted | Aug 8, 2003 |
| Last update posted | Oct 3, 2006 |
| Countries | Canada, South Africa, United Kingdom, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: